6 authorised products containing Topotecan hydrochloride, from the HPRA register.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| HYCAMTIN 0.25 mg hard capsules EU/1/96/027/006 |
Topotecan hydrochloride | Sandoz Pharmaceuticals d.d. | — |
| HYCAMTIN 1 mg hard capsules EU/1/96/027/007 |
Topotecan hydrochloride | Sandoz Pharmaceuticals d.d. | — |
| Hycamtin 4 mg powder for concentrate for solution for infusion EU/1/96/027/003 |
Topotecan hydrochloride | Sandoz Pharmaceuticals d.d. | — |
| HYCAMTIN 4 mg powder for concentrate for solution for infusion EU/1/96/027/001 |
Topotecan hydrochloride | Sandoz Pharmaceuticals d.d. | — |
| Potactasol 1 mg powder for concentrate for solution for infusion EU/1/10/660/001 |
Topotecan hydrochloride | Actavis Group hf | — |
| Potactasol 4 mg powder for concentrate for solution for infusion EU/1/10/660/002 |
Topotecan hydrochloride | Actavis Group hf | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 5 July 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.